Accountability, Pharmaceuticals, Public Health services and Regulations

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Accountability

Pharmaceuticals

Public Health services

Regulations

CMS Releases Guidance on Implementation of Rebate Programs for Certain Medicare Part B and Part D Drugs

Sheppard Health Law

FEBRUARY 22, 2023

All rebate payments will be deposited into the Medicare Prescription Drug Account in the Federal Supplementary Medical Insurance Trust Fund. Is the Guidance Final or Open to Comment? Interestingly, the answer is – both. Part D inflation rebates are measured on an annual basis, with the first measuring period having begun on October 1, 2022.

Medicare

Medicare Medicaid Pharmaceuticals Public Health services

Healthcare Reforms Under the IRA: Expanding Access to Care

Sheppard Health Law

AUGUST 25, 2022

Nonetheless, additional clarification in the form of regulations is anticipated, as the text of the IRA defers multiple matters to the Department of Health and Human Services (“HHS”) for implementation. A safe harbor applicable to flat fee arrangements paid by pharmaceutical manufacturers directly to PBMs for PBM services.

Healthcare

Healthcare Medicare Pharmaceuticals Medicaid

Health Care Quality Digest

CMS Releases Guidance on Implementation of Rebate Programs for Certain Medicare Part B and Part D Drugs

Healthcare Reforms Under the IRA: Expanding Access to Care

Stay Connected